Neutron Holdings, Inc. (LIME)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $2.5M
- Jul 2 · No plan
- Form 4 sales
- 2
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- Dec 9
- in 17 days · Assumed
Lockups
Dec 9, 2026
Ends in 17 days · Assumed date
- IPO lockupAssumed dateDec 9, 2026 in 17 days
160 days . The prospectus also states 90 days and 18 months.
Early release terms, quoted from the prospectus
Sales of a substantial number of such shares upon expiration of the lock-up and market standoff agreements, the perception that such sales may occur, or early release of these agreements could cause the market price of our common stock to fall or make it more difficult for an investor to sell our common stock at a time and price that an investor deems appropriate.
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Timeline
- 1 Form 4 saleNo planJul 2, 2026 2026
Sold 73,397 shares at $25.00 ($1.8M)
Bao Zhoujia, Director
No 10b5-1 planSold 9.9% of holdings ($18.6M position)668,859 shares leftFirst sale on recordFiling
- 2 Form 4 saleNo planJul 2, 2026 same day
Sold 99,115 shares at $25.00 ($2.5M)
Ting Wayne Hsing-Yuan, Chief Executive Officer
No 10b5-1 planSold 18.6% of holdings ($13.3M position)433,351 shares leftFirst sale on recordFiling
- 3 Lockup expiryLockup ends, assumedSep 30, 2026 +90 days
Lockup assumed to end
Assumed dateFiling
- 4 Lockup expiryLockup ends, assumedDec 9, 2026 +70 days
Lockup assumed to end
Assumed dateFiling
- 5 Lockup expiryLockup ends, assumedJan 2, 2028 +389 days
Lockup assumed to end
Assumed dateFiling
Every transaction
Loading transactions…
Sales, notices and lockups (5)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2028 | Jul 1, 2026 | All locked holders | Lockup expiry | Lockup ends, assumed | SEC | ||||
| Dec 9, 2026 | Jul 1, 2026 | All locked holders | Lockup expiry | Lockup ends, assumed | SEC | ||||
| Sep 30, 2026 | Jul 1, 2026 | All locked holders | Lockup expiry | Lockup ends, assumed | SEC | ||||
| Jul 2, 2026 | Jul 2, 2026 | Ting Wayne Hsing-Yuan | Chief Executive Officer | Form 4 sale | 99,115 | $2.5M | 18.6% | No plan | SEC |
| Jul 2, 2026 | Jul 2, 2026 | Bao Zhoujia | Director | Form 4 sale | 73,397 | $1.8M | 9.9% | No plan | SEC |